BOTANIQUE Reformulates Major Products from CBN to CBG
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
BOTANIQUE, a biotech startup specializing in research and commercialization of new materials, has reformulated its key products from CBN (Cannabinol) to CBG (Cannabigerol). The company successfully raised approximately ¥150 million in Series A funding in May 2022 and has experience in researching nano CBD formulations that drastically improve CBD absorption efficiency and supplying CBD products to over 500 locations nationwide, including medical institutions.